Endothelin-1 and Adrenomedullin Plasma Levels After Exposure to Fludrocortisone, Dexamethasone, and Spironolactone

REFERENCES

• Yanagisawa M, Kurihara H, Kimura S, . A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411–415.
   PubMed Web of Science ®Google Scholar
• Ishimitsu T, Nishikimi T, Saito Y, . Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94:2158–2161.
   PubMed Web of Science ®Google Scholar
• Hernández-Hernández R, Sosa-Canache B, Velasco M, Armas-Hernández MJ, Armas-Padilla MC, Cammarata R. Angiotensin II receptor antagonists role in arterial hypertension. J Hum Hypertens 2002; 16(Suppl. 1):S93–S99.
   PubMed Web of Science ®Google Scholar
• Weber MA, Black H, Bakris G, . A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet 2009; 24(374):1423–1431.
   Google Scholar
• Yang Bo, Chen YD, Li TD, Feng QZ. Endothelin-1 receptor blockade induces upregulation of renin–angiotensin–aldosterone system expression in terms of blood pressure regulation. J Renin Angiotensin Aldosterone Syst 2010; 11:119–123.
   PubMed Web of Science ®Google Scholar
• Miller WL, Redfield MM, Burnett JC Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 1989; 83:317–320.
   PubMed Web of Science ®Google Scholar
• Hinson JP, Kapas S, Teja R, Vinson GP. Effect of the endothelins on aldosterone secretion by rat zona glomerulosa cells in vitro. J Steroid Biochem Mol Biol 1991; 40:437–439.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Sacchetto A, Cesari M, Pessina AC. Interactions between endothelin-1 and the renin–angiotensin–aldosterone system. Cardiovasc Res 1999; 43:300–307.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Belloni AS, Nussdorfer GG, Pessina AC. Endothelin-1 and the adrenal gland. J Cardiovasc Pharmacol 2000; 35:S17–S20.
   Google Scholar
• Delarue C, Conlon JM, Remy-Jouet I, Fournier A, Vaudry H. Endothelins as local activators of adrenocortical cells. J Mol Endocrinol 2004; 32:1–7.
   PubMed Web of Science ®Google Scholar
• Stow LR, Gumz ML, Lynch IJ, . Aldosterone modulates steroid receptor binding to the endothelin-1 gene (edn1). J Biol Chem 2009; 284:30087–30096.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Kangawa K, Kawamoto M, . Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192:553–560.
   PubMed Web of Science ®Google Scholar
• Ishiyama Y, Kitamura K, Ichiki Y, . Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 1993; 241:271–273.
   PubMed Web of Science ®Google Scholar
• Hinson JP, Kapas S. The role of endothelial cell products in the regulation of adrenocortical function: actions of endothelin, nitric oxide, adrenomedullin and PAMP. Horm Metab Res 1998; 30: 334–340.
   PubMed Web of Science ®Google Scholar
• Hamid SA, Baxter GF. Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction. Pharmacol Ther 2005; 105:95–112.
   PubMed Web of Science ®Google Scholar
• Kita T, Kitamura K, Kuwasako K, Kawamoto M, Eto T. Short-term modulation of the renin–angiotensin system does not alter plasma adrenomedullin concentration in humans. J Hypertens 1998; 16:2057–2062.
   PubMed Web of Science ®Google Scholar
• Nussdorfer GG, Rossi GP, Mazzocchi G. Role of adrenomedullin and related peptides in the regulation of the hypothalamo–pituitary–adrenal axis. Peptides 1997; 18:1079–1089.
   PubMed Web of Science ®Google Scholar
• Mazzocchi G, Musajo F, Neri G, Gottardo G, Nussdorfer GG. Adrenomedullin stimulates steroid secretion by the isolated perfused rat adrenal gland in situ: comparison with calcitonin gene-related peptide effects. Peptides 1996; 17:853–857.
   PubMed Web of Science ®Google Scholar
• Andreis PG, Neri G, Prayer-Galetti T, . Effects of adrenomedullin on the human adrenal glands: an in vitro study. J Clin Endocrinol Metab 1997; 82:1167–1170.
   PubMed Web of Science ®Google Scholar
• Thomson LM, Kapas S, Hinson JP. Proadrenomedullin N-terminal 20 peptide (PAMP) stimulates aldosterone secretion by the intact rat adrenal glomerulosa by a cAMP-dependent mechanism. FEBS Lett 1998; 432:37–39.
   PubMed Web of Science ®Google Scholar
• Nussdorfer GG, Rossi GP, Belloni AS. The role of endothelins in the paracrine control of the secretion and growth of the adrenal cortex. Int Rev Cytol 1997; 171:267–308.
   PubMed Web of Science ®Google Scholar
• Willenberg HS, Kolentini C, Quinkler M, . The sodium to urinary sodium to (potassium)2 to urinary potassium (SUSPPUP) ratio in primary aldosteronism. Eur J Clin Invest 2009; 39:43–50.
   PubMed Web of Science ®Google Scholar
• Morello F, Schiavone D, Mengozzi G, . Adrenal endothelin-1 levels are not associated with aldosterone secretion in primary aldosteronism. Eur J Endocrinol 2009; 160:453–458.
   PubMed Web of Science ®Google Scholar
• Veglio F, Melchio R, Rabbia F, Chiandussi L. Plasma immunoreactive endothelin-1 in primary hyperaldosteronism. Am J Hypertens 1994; 7:559–561.
   PubMed Web of Science ®Google Scholar
• Paramonova I, Haase M, Mülders-Opgenoorth B, . The effects of the endothelium on adrenal steroidogenesis is mediated by proteins other than endothelin-1. Horm Metab Res 2010; 42:840–845.
   PubMed Web of Science ®Google Scholar
• Moe O, Tejedor A, Campbell WB, Alpern RJ, Henrich WL. Effects of endothelin on in vitro renin secretion. Am J Physiol 1991; 260:E521–E525.
   PubMed Web of Science ®Google Scholar
• Krämer BK, Ritthaler T, Ackermann M, . Endothelium-mediated regulation of renin secretion. Kidney Int 1994; 46: 1577–1579.
   PubMed Web of Science ®Google Scholar
• Ritthaler T, Scholz H, Ackermann M, Riegger G, Kurtz A, Krämer BK. Effects of endothelins on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol 1995; 268:F39–F45.
   Google Scholar
• Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Bühler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1990; 1:649–659.
   PubMedGoogle Scholar
• Scott-Burden T, Resink TJ, Hahn AW, Vanhoutte PM. Induction of endothelin secretion by angiotensin II: effects on growth and synthetic activity of vascular smooth muscle cells. J Cardiovasc Pharmacol 1991; 17:S96–S100.
   PubMed Web of Science ®Google Scholar
• Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992; 19:753–757.
   PubMed Web of Science ®Google Scholar
• Chua BH, Chua CC, Diglio CA, Siu BB. Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1993; 1178:201–206.
   PubMed Web of Science ®Google Scholar
• Sung CP, Arleth AJ, Storer BL, Ohlstein EH. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J Pharmacol Exp Ther 1994; 271:429–437.
   PubMed Web of Science ®Google Scholar
• Pecci A, Cozza EN, Devlin M, Gomez-Sanchez CE, Gomez-Sanchez EP. Endothelin-1 stimulation of aldosterone and zona glomerulosa ouabain-sensitive sodium/potassium-ATPase. J Steroid Biochem Mol Biol 1994; 50:49–53.
   PubMed Web of Science ®Google Scholar
• Charles CJ, Lainchbury JG, Nicholls MG, Rademaker MT, Richards AM, Troughton RW. Adrenomedullin and the renin–angiotensin–aldosterone system. Regul Pept 2003; 112:41–49.
   PubMed Web of Science ®Google Scholar
• Letizia C, Centanni M, Scuro L, . High plasma levels of endothelin-1 in untreated Addison’s disease. Eur J Endocrinol 1996; 135:696–699.
   PubMed Web of Science ®Google Scholar
• Willenberg HS, Schinner S, Ansurudeen I. New mechanisms to control aldosterone synthesis. Horm Metab Res 2008; 40:435–441.
   PubMed Web of Science ®Google Scholar
• Letizia C, Cerci S, Centanni M, . Circulating levels of adrenomedullin in patients with Addison’s disease before and after corticosteroid treatment. Clin Endocrinol 1998; 48:145–148.
   PubMed Web of Science ®Google Scholar
• Letizia C, D’Erasmo E, Subioli S, . Plasma levels of adrenomedullin in patients with adrenoleukodystrophy/adrenomyeloneuropathy. Horm Res 2005; 63:90–94.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Baba K, Doi Y, Yano K. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci 1995; 56:379–387.
   PubMed Web of Science ®Google Scholar
• Mazzocchi G, Rebuffat P, Gottardo G, Nussdorfer GG. Adrenomedullin and calcitonin gene-related peptide inhibit aldosterone secretion in rats, acting via a common receptor. Life Sci 1996; 58:839–844.
   PubMed Web of Science ®Google Scholar
• AYamaguchi T, Baba K, Doi Y, Yano K, Kitamura K, Eto T. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat. Hypertension 1996; 28:308–314.
   PubMed Web of Science ®Google Scholar
• ndreis PG, Markowska A, Champion HC, Mazzocchi G, Malendowicz LK, Nussdorfer GG. Adrenomedullin enhances cell proliferation and deoxyribonucleic acid synthesis in rat adrenal zona glomerulosa: receptor subtype involved and signaling mechanism. Endocrinology 2000; 141:2098–2104.
   PubMed Web of Science ®Google Scholar
• Kato K, Kitamura K, Kuwasako K, . Plasma adrenomedullin in patients with primary aldosteronism. Am J Hypertens 1995; 8:997–1000.
   PubMed Web of Science ®Google Scholar
• Letizia C, De Toma G, Cerci S, . Adrenomedullin levels are high in primary aldosteronism due to adenoma and decline after surgical cure. Blood Press 1998; 7:19–23.
   PubMedGoogle Scholar